Dermatology News

• Alert FDA Approves Autoinjector Pen for Humira Biosimilar, Cyltezo The drug will be commercially available on July 1, 2023.
  Medscape Medical News, May 22, 2023
• SPARTAN 2023 TNF, JAK Inhibitors' CV Safety Compared in PsA, AxSpA JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.
  MDedge News, May 19, 2023
• AMA President on Fighting Prior Auth, Scope Creep, and More The president of the American Medical Association, Jack Resneck Jr, MD, discusses government interference in healthcare, the prior authorization mess, and more in a wide-ranging interview with Medscape.
  Medscape Medical News, May 19, 2023
• The Antimicrobial Peptide That Even Pharma Can Love Those antibiotics may kill 99.9% of germs, but what about the 0.1% that gets left behind?
  MDedge News, May 18, 2023
• SGIM 2023 Pop This Question to Improve Medication Adherence If you're not talking with your patients about how they can save money on their healthcare, you're missing an opportunity to improve outcomes.
  Medscape Medical News, May 18, 2023
• Drug Shortages in US at 10-Year High Drug shortages hit a 10-year high in early 2023. Among the current shortage are 15 cancer drugs, some of which lack an effective alternative.
  Medscape Medical News, May 18, 2023
• ACMS 2023 Genetic Profiling Identifies High-Risk Cutaneous SCC Tumors Study results identified genes that were both significantly upregulated and downregulated in high-risk T2a tumors.
  Medscape Medical News, May 18, 2023
• ACMS 2023 Mohs Surgery Saves Costs, May Improve Outcomes in Melanoma Even though upfront costs are higher for Mohs surgery, there can be substantial savings longer term, as well as reduced morbidity for patients.
  Medscape Medical News, May 17, 2023
• Brepocitinib Shows Promise for Patients With PsA Data from a phase 2b trial showed superior symptom reduction, compared with placebo, by 1 year.
  MDedge News, May 17, 2023
• CDC Warns of Mpox Resurgence This Summer "The outbreak is not over," the CDC alert stated, noting that springtime and summertime gatherings and festivals could lead to renewed virus spread.
  WebMD Health News, May 17, 2023
• Doctors Fervently Hope Fed Ban on Noncompetes Gets Passed Noncompete agreements, a long-standing thorn in the side of physicians and other clinicians, may become a thing of the past depending on an upcoming final decision.
  Medscape Medical News, May 16, 2023
• ARVO 2023 Foot Ulcers Red Flag for Eye Disease in Diabetes The presence of diabetic foot ulcers may impede the care of retinopathy, researchers have found.
  Medscape Medical News, May 15, 2023
• AACE 2023 Noninvasive Skin Test May Aid in Cushing Diagnosis A device that measures tissue accumulation of advanced glycation end products can point to endogenous hypercortisolism.
  Medscape Medical News, May 15, 2023
• IVIG Shows No Impact on VTE Risk in Dermatomyositis Patients The rate of venous thromboembolism did not increase in dermatomyositis patients treated with intravenous immunoglobulin, compared with those not treated with IVIG.
  MDedge News, May 12, 2023
• Cutaneous Vasculitis Curtails Quality of Life Survey respondents described generally poor health-related quality of life (QoF) that was characterized as being more severe with a skin-specific instrument than with a generic health-related QoF index.
  MDedge News, May 12, 2023
• FDA Clears Renuvion APR Handpiece for Use After Liposuction The agency’s update on Wednesday follows three updates on the Renuvion/J-Plasma system in 2022.
  Medscape Medical News, May 11, 2023
• ASLMS 2023 Picosecond Laser Applications Continue to Expand Several FDA-cleared picosecond devices are used to treat nevus of Ota, café-au-lait macules, lentigines, melasma, and photoaging, as well as for removing tattoos.
  MDedge News, May 11, 2023
• Dupilumab Benefits Shown in Phase 3 Prurigo Nodularis Trials The results "support the involvement of type 2 cytokines in driving PN disease pathogenesis and the targeting of the IL-4/IL-13 axis as a novel therapeutic paradigm" for PN, the authors write.
  MDedge News, May 11, 2023
• CDC Cuts Back Hospital Data Reporting on COVID Some experts wonder whether CDC will have enough timely information to guide public health decisions if the virus comes roaring back.
  Medscape Medical News, May 11, 2023
• PAS 2023 Can This Tool Forecast Peanut Allergies? Until now, little effort has gone to categorizing eczema on the basis of severity and to correlating peanut allergy risk.
  Medscape Medical News, May 10, 2023